Change in severity of symptoms during enteral infusion [ Time Frame: baseline, every 15 minutes up to 8 hours ]
Visual analog scale (VAS) used to measure the change in symptom severity with a scale of 0=absent, 1=light, 2=moderate, 3=severe, 4=intolerable
Change in severity of symptoms during gastric emptying study [ Time Frame: baseline, every 15 minutes up to 2 hours ]
Visual analog scale (VAS) used to measure the change in symptom severity with a scale of 0=absent, 1=light, 2=moderate, 3=severe, 4=intolerable
Change in severity of daily symptoms [ Time Frame: Baseline, daily for six weeks ]
Gastroparesis Cardinal Symptom Index – Daily Diary (GCSI-DD) used to measure the change in symptoms severity with a scale of 0=none, 1= very mild, 2=mild,3=moderate, 4=severe, 5= very severe
Change in severity of gastrointestinal symptoms [ Time Frame: Baseline, 2 weeks, 6 weeks ]
Gastrointestinal Disorders – Symptom Severity Index (PAGI-SYM) used to measure the change in symptoms severity with a scale of 0=none, 1= very mild, 2=mild,3=moderate, 4=severe, 5= very severe
Change in severity of gastrointestinal symptoms effect on Quality of Life [ Time Frame: Baseline, 2 weeks, 6 weeks ]
Gastrointestinal Disorders – Quality of Life and Well-Being (PAGI-QOL) used to measure the change in symptoms severity with a scale of 0=none, 1= very mild, 2=mild,3=moderate, 4=severe, 5= very severe
Change in effect of Gastrointestinal symptoms on Quality of Life [ Time Frame: Baseline ]
Nepean Dyspepsia Index used to measure symptoms severity with a scale of 0=none, 1= very mild, 2=mild,3=moderate, 4=severe, 5= very severe
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
